-
Something wrong with this record ?
MR enterography with a new negative oral contrast solution containing maghemite nanoparticles
I. Markova, K. Polakova, P. Tucek, M. Mashlan, P. Novak, R. Zboril, M. Herman
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
- MeSH
- Crohn Disease diagnosis MeSH
- Adult MeSH
- Contrast Media * adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Cholangiopancreatography, Magnetic Resonance MeSH
- Magnetic Resonance Imaging * MeSH
- Adolescent MeSH
- Young Adult MeSH
- Nanoparticles * MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Intestine, Small pathology MeSH
- Ferric Compounds adverse effects diagnostic use MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIM: The aim of this study was to test an oral contrast solution with maghemite for the magnetic resonance imaging of small bowel diseases. PATIENTS AND METHODS: The study sample included 3 cohorts: 17 healthy volunteers (group A), 22 patients with small bowel disease (group C). Both groups underwent MR enterography and 24 patients with small bowel disease (group B) underwent magnetic resonance cholecystopancreaticography. Various concentrations in 1000 ml vs 500 ml of experimental solution were tested. All cohorts completed questionnaires evaluating the solution characteristics and side-efects during and after drinking. RESULTS: A maghemite concentration of 800 mg /4 g bentonite in 1000 ml solution was sufficient for proper intraluminal lay-out. An experimental solution of 500 ml was sufficient for magnetic resonance cholecystopancreaticography and 1000 ml for MR enterography. There were no statistically significant differences between groups for taste, taste characteristic or appearance of the experimental solution. Side-effects experienced during drinking were: nausea (29.4%) and eructation (29.4%) in group A, in group B (42%) and diarrhoea (27.3%) in group C. Side-effects 2 h after drinking occured in group A (nausea 17.6%) and in group C (diarrhoea 47%). The best tolerance of experimental solution was found in group B with a higher median patient age than groups A and C. The experimental solution was evaluated more favorably in the older subjects (age over 50 years). CONCLUSION: The experimental oral solution with maghemite was well tolerated in all 3 groups. Our study supports its use in magnetic resonance practice.
Center for Nanomaterial Research Palacky University Olomouc
Department of Geoinformatics Faculty of Science Olomouc
Department of Radiology F D Roosevelt Faculty Hospital Banska Bystrica
Department of Radiology Faculty of Medicine and Dentistry Palacky University Olomouc
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13039574
- 003
- CZ-PrNML
- 005
- 20140109090651.0
- 007
- ta
- 008
- 131218s2012 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2012.001 $2 doi
- 035 __
- $a (PubMed)22660214
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Marková, Ingrid $7 xx0106391 $u Department of Radiology, F. D. Roosevelt Faculty Hospital, Banska Bystrica; Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc
- 245 10
- $a MR enterography with a new negative oral contrast solution containing maghemite nanoparticles / $c I. Markova, K. Polakova, P. Tucek, M. Mashlan, P. Novak, R. Zboril, M. Herman
- 520 9_
- $a AIM: The aim of this study was to test an oral contrast solution with maghemite for the magnetic resonance imaging of small bowel diseases. PATIENTS AND METHODS: The study sample included 3 cohorts: 17 healthy volunteers (group A), 22 patients with small bowel disease (group C). Both groups underwent MR enterography and 24 patients with small bowel disease (group B) underwent magnetic resonance cholecystopancreaticography. Various concentrations in 1000 ml vs 500 ml of experimental solution were tested. All cohorts completed questionnaires evaluating the solution characteristics and side-efects during and after drinking. RESULTS: A maghemite concentration of 800 mg /4 g bentonite in 1000 ml solution was sufficient for proper intraluminal lay-out. An experimental solution of 500 ml was sufficient for magnetic resonance cholecystopancreaticography and 1000 ml for MR enterography. There were no statistically significant differences between groups for taste, taste characteristic or appearance of the experimental solution. Side-effects experienced during drinking were: nausea (29.4%) and eructation (29.4%) in group A, in group B (42%) and diarrhoea (27.3%) in group C. Side-effects 2 h after drinking occured in group A (nausea 17.6%) and in group C (diarrhoea 47%). The best tolerance of experimental solution was found in group B with a higher median patient age than groups A and C. The experimental solution was evaluated more favorably in the older subjects (age over 50 years). CONCLUSION: The experimental oral solution with maghemite was well tolerated in all 3 groups. Our study supports its use in magnetic resonance practice.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a magnetická rezonanční cholangiopankreatografie $7 D049448
- 650 12
- $a kontrastní látky $x škodlivé účinky $7 D003287
- 650 _2
- $a Crohnova nemoc $x diagnóza $7 D003424
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a železité sloučeniny $x škodlivé účinky $x diagnostické užití $7 D005290
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tenké střevo $x patologie $7 D007421
- 650 12
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nanočástice $7 D053758
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Poláková, Kateřina $u Regional Center of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University Olomouc $7 xx0139779
- 700 1_
- $a Tuček, Pavel $u Department of Geoinformatics, Faculty of Science, Olomouc $7 _AN051497
- 700 1_
- $a Mašláň, Miroslav, $u Center for Nanomaterial Research, Palacky University Olomouc $d 1957- $7 mzk2003202659
- 700 1_
- $a Novák, Pavel $u Medihope s.r.o., Prostejov $7 _AN042119
- 700 1_
- $a Zbořil, Radek, $u Regional Center of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University Olomouc $d 1973- $7 xx0140669
- 700 1_
- $a Heřman, Miroslav, $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc $d 1959- $7 jn20000400945
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 156, č. 3 (2012), s. 229-235
- 856 41
- $u http://biomed.papers.upol.cz/magno/bio/2012/mn3.php $y domovská stránka časopisu - plný text volně přístupný = fulltext
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20131218 $b ABA008
- 991 __
- $a 20140109091352 $b ABA008
- 999 __
- $a ok $b bmc $g 1005872 $s 838075
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 156 $c 3 $d 229-235 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $a Pubmed-20131218
